Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 96

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 96
---
2024, and (C) the estimated fair value of any equity awards granted during the fiscal year ended December 31, 2024 and, (ii) ranking this aggregated compensation measure for our employees from lowest to highest. This calculation was performed for all employees, excluding Mr. Goff, our chief executive officer.Mr. Goff’s 2024 compensation, for purposes of this pay ratio disclosure, was $6,776,359.The annual total compensation for our median employee for 2024 was $331,591resulting in a pay ratio of approximately 20 to 1.The pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC regulations based on our internal records and the methodology described above. The SEC regulation for identifying the median compensated employee and calculating the pay ratio based on that employee’s annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their employee populations and compensation practices. Therefore, the pay ratio reported by other companies may not be comparable to the pay ratio reported above, as other companies have different employee populations and compensation practices and may utilize different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.72
Pay Versus Performance Disclosure

In accordance with rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide the following disclosure regarding executive compensation for our principal executive officers, or PEOs, and Non-PEO NEOs and company performance for the fiscal years listed below. The compensation & people committee did not consider the pay versus performance disclosure below in making its compensation decisions for any of the years shown. For discussion of how our compensation & people committee seeks to align pay with performance when making compensation decisions, please review Compensation Discussion and Analysis beginning on page 40 of this Proxy Statement.

| Year |                           | SummaryCompensationTable Totalfor PEO 1(1)($) |           |     |                                     | SummaryCompensationTable Totalfor PEO 2(1)($) |            |     | CompensationActually Paidto PEO 1(1)(2)(3)($) |           |     | CompensationActually Paidto PEO2(1)(2)(3)($) |            |     | AverageSummaryCompensationTable Totalfor Non-PEONEOs(1)($) |           |     | AverageCompensationActually PaidtoNon-PEONEOs(1)(2)(3)($) |           |